Cargando…
A Novel Cell-Free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Functional Activity of HDL
Aims: A functional abnormality in high-density lipoprotein (HDL) particles rather than a quantitative abnormality in HDL cholesterol levels has been suggested to promote atherosclerosis. The modification of HDL may underlie functional changes to HDL such as gaining the ability to bind and activate t...
Autores principales: | Kakino, Akemi, Usami, Yoko, Horiuchi, Sayaka, Fujita, Yoshiko, Kotani, Kazuhiko, Chen, Chu-Huang, Okamura, Tomonori, Sawamura, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6845692/ https://www.ncbi.nlm.nih.gov/pubmed/30944265 http://dx.doi.org/10.5551/jat.47183 |
Ejemplares similares
-
LOX-1 in Ischemic Stroke
por: Sawamura, Tatsuya, et al.
Publicado: (2017) -
The Discovery of LOX-1, its Ligands and Clinical Significance
por: Yoshimoto, Ryo, et al.
Publicado: (2011) -
Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin
por: Yokoyama, Chiharu, et al.
Publicado: (2016) -
Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox
por: NISHIZUKA, Taichi, et al.
Publicado: (2011) -
Erratum to “Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox”: [Proc. Jpn. Acad., Ser. B 87, No. 3, 104–113]
por: NISHIZUKA, Taichi, et al.
Publicado: (2011)